BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1780327)

  • 1. Effect of octreotide, a long-acting somatostatin analogue, on plasma amino acid uptake by the pancreas.
    Gullo L; Pezzilli R; Ancona D; Labate AM; Barbara L
    Pancreas; 1991 Nov; 6(6):668-72. PubMed ID: 1780327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pancreatic polypeptide, thyrotropin-releasing hormone, and glucagon on plasma amino acid uptake by human pancreas.
    Gullo L
    Gastroenterology; 1991 Apr; 100(4):1095-9. PubMed ID: 1900491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin on plasma amino acid uptake by human pancreas.
    Gullo L; Pezzilli R; Barbara L
    Gastroenterology; 1989 Sep; 97(3):732-6. PubMed ID: 2568964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995).
    Kemmer TP; Malfertheiner P; Büchler M; Friess H; Meschenmoser L; Ditschuneit H
    Aliment Pharmacol Ther; 1992 Feb; 6(1):41-50. PubMed ID: 1371938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin analogues and exocrine pancreatic secretion.
    Gullo L
    Digestion; 1996; 57 Suppl 1():93. PubMed ID: 8813482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amino acid consumption and pancreatic secretion during and after cerulein-induced pancreatitis in rats.
    Fischer H; Konturek JW; Szlachcic A; Konturek SJ; Domschke W
    Int J Pancreatol; 1995 Oct; 18(2):127-34. PubMed ID: 8530828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new somatostatin analogue on pancreatic function in healthy volunteers.
    Köhler E; Beglinger C; Dettwiler S; Whitehouse I; Gyr K
    Pancreas; 1986; 1(2):154-9. PubMed ID: 2437563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
    Friess H; Bordihn K; Ebert M; Malfertheiner P; Kemmer T; Dennler HJ; Büchler MW
    Digestion; 1994; 55 Suppl 1():10-5. PubMed ID: 8132133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of octreotide (SMS 201-995) on meal-stimulated pancreatic secretion in three patients with external pancreatic fistula.
    Gullo L; Biliotti G; Pezzilli R; Di Stefano M; Ancona D
    Am J Gastroenterol; 1991 Jul; 86(7):892-4. PubMed ID: 2058634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat pancreas after long-term treatment with the somatostatin analogue octreotide.
    von Schönfeld J; Meisse F; Müller MK
    Exp Physiol; 1995 Nov; 80(6):1031-8. PubMed ID: 8962703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin (CCK) in the amino acid uptake and enzyme protein secretion by the pancreas in humans.
    Konturek JW; Gabryelewicz A; Kulesza E; Konturek SJ; Domschke W
    Int J Pancreatol; 1995 Feb; 17(1):55-61. PubMed ID: 8568335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
    Harris AG
    Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does somatostatin analogue prevent experimental acute pancreatitis?
    Murayama KM; Drew JB; Joehl RJ
    Arch Surg; 1990 Dec; 125(12):1570-2. PubMed ID: 2244811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat.
    Hajri A; Aprahamian M; Damgé C
    Regul Pept; 1991 Feb; 32(2):227-37. PubMed ID: 1709749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous observation of endocrine and exocrine functions of the pancreas responding to somatostatin in man.
    Emoto T; Miyata M; Izukura M; Yumiba T; Mizutani S; Sakamoto T; Matsuda H
    Regul Pept; 1997 Jan; 68(1):1-8. PubMed ID: 9094748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the thyroid on exocrine pancreatic function.
    Gullo L; Pezzilli R; Bellanova B; D'Ambrosi A; Alvisi V; Barbara L
    Gastroenterology; 1991 May; 100(5 Pt 1):1392-6. PubMed ID: 2013384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacological effects of SMS 201-995 on gastric secretion.
    Gyr KE; Whitehouse I; Beglinger C; Köhler E; Dettwiler S; Fried M
    Scand J Gastroenterol Suppl; 1986; 119():96-102. PubMed ID: 2876511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pancreastatin on cerulein-stimulated pancreatic blood flow and exocrine secretion in anaesthetized rats.
    Migita Y; Nakano I; Goto M; Ito T; Nawata H
    J Gastroenterol Hepatol; 1999 Jun; 14(6):583-7. PubMed ID: 10385069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of SMS 201-995 on exocrine pancreatic secretion in a patient with external pancreatic fistula.
    Ohta T; Nagakawa T; Mori K; Kanno M; Kayahara M; Ueno K; Miyazaki I
    Int J Pancreatol; 1992 Jun; 11(3):185-9. PubMed ID: 1517658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.